[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:alcoholic-hepatitis":3},{"name":4,"total":5,"recruiting":5,"trials":6,"biomarkers":53,"states":54},"Alcoholic Hepatitis",7,[7,14,21,27,33,39,46],{"nct_id":8,"title":9,"phases":10,"status":11,"updated_at":12,"content_modified":13},"NCT03845205","Alcohol Treatment Outcomes Following Early vs. Standard Liver Transplant for SAH",[],"RECRUITING","2026-08-26T02:17:12.307088Z","2026-05-05T02:43:26.965885Z",{"nct_id":15,"title":16,"phases":17,"status":11,"updated_at":19,"content_modified":20},"NCT05178069","LGG Supplementation in Patients With AUD and ALD",[18],"Phase 2","2026-08-26T02:17:33.002248Z","2026-05-05T02:43:29.699360Z",{"nct_id":22,"title":23,"phases":24,"status":11,"updated_at":25,"content_modified":26},"NCT04088370","Peripheral Blood Mononuclear Cells Response In Healthy Controls, Heavy Drinkers, and Patients With Alcoholic Hepatitis",[],"2026-08-26T02:16:18.872924Z","2026-05-13T02:55:06.233430Z",{"nct_id":28,"title":29,"phases":30,"status":11,"updated_at":31,"content_modified":32},"NCT07060547","Investigating HepQuant DuO Test as a Biomarker in Alcohol-related Liver Disease",[],"2026-08-26T02:15:21.365312Z","2026-05-13T02:55:06.649826Z",{"nct_id":34,"title":35,"phases":36,"status":11,"updated_at":37,"content_modified":38},"NCT03224949","Comparison of ALD, NASH, and Healthy Control Patients",[],"2026-08-26T02:19:24.527214Z","2026-05-13T02:55:06.121030Z",{"nct_id":40,"title":41,"phases":42,"status":11,"updated_at":44,"content_modified":45},"NCT05018481","HA35 Moderate Alcoholic Hepatitis (AH) Study",[43],"Early Phase 1","2026-08-26T02:16:45.157238Z","2026-05-05T02:43:28.795919Z",{"nct_id":47,"title":48,"phases":49,"status":11,"updated_at":51,"content_modified":52},"NCT05006430","Safety Evaluation of Fecal Microbiota Transplantation in Severe Alcoholic Hepatitis",[50],"Phase 1\u002FPhase 2","2026-08-26T02:15:49.658025Z","2026-05-05T02:43:26.716777Z",[],[55],{"state":56,"count":57,"slug":58},"Ohio",3,"ohio"]